Professor Michelle Glass
Molecular Pharmacologist, Head of the Department of Pharmacology and Toxicology, Otago University, NZ
Professor Michelle Glass took up the position of Head of the Department of Pharmacology and Toxicology in July 2018, after 17 years at the University of Auckland, including six years as the Head of Pharmacology and Clinical Pharmacology.
As a molecular pharmacologist, Professor Glass’ research focuses on the expression, function and molecular pharmacology of the cannabinoid receptors and their potential role in treatment of neurodegenerative diseases. Her recent research interests have extended to identifying the mechanism by which synthetic cannabinoids are resulting in high levels of toxicity in the community.
Following her PhD in which she mapped the then newly discovered cannabinoid CB1 receptor in the human brain, she worked as a postdoctoral Fellow at the National Institutes of Health in Bethesda, Maryland for five years before returning to New Zealand in 2000 to take up a role as a Lecturer within the Department of Pharmacology at the University of Auckland. She has published over 80 papers on cannabinoids, and numerous book chapters. Her contributions to the field have been acknowledged by an early career award from the International Cannabinoid Research Society in 2009 and by election to President of this society in 2015.